Qingyang Gu
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Overview of Preclinical Drug-Resistant Tumor Models and Their Application in Drug Discovery.
Journal: Current protocols
Published: December 10, 2025
Developing Monosodium Urate Monohydrate Crystals-Induced Gout Model in Rodents and Rabbits.
Journal: Current protocols
Published: March 27, 2025
Development, Characterization, and Therapeutic Utility of Paclitaxel-Resistant Breast and Gastric Cancer In Vitro and In Vivo Models.
Journal: Current protocols
Published: March 03, 2025
Developing a Novel Enzalutamide-Resistant Prostate Cancer Model via AR F877L Mutation in LNCaP Cells.
Journal: Current protocols
Published: April 23, 2024
Melanocortin-4 receptor antagonist TCMCB07 alleviates chemotherapy-induced anorexia and weight loss in rats.
Journal: The Journal of clinical investigation
Published: March 21, 2024
Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines.
Journal: Chemical engineering journal (Lausanne, Switzerland : 1996)
Published: September 01, 2022
Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer.
Journal: Cell research
Published: March 22, 2019
The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors.
Journal: Science signaling
Published: September 13, 2018
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma.
Journal: Oncotarget
Published: June 08, 2017
Establishing a patient-derived xenograft model of human myxoid and round-cell liposarcoma.
Journal: Oncotarget
Published: September 18, 2016
Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
Journal: Hepatology (Baltimore, Md.)
Published: September 09, 2016
Last Updated: 09/26/2026